Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06874374 · ClinicalTrials.gov registry record · NA

Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder

A NA study of Depression - Major Depressive Disorder and Transcranial Alternating Current Stimulation, sponsored by Pulvinar Neuro.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06874374 is a NA study of Depression - Major Depressive Disorder and Transcranial Alternating Current Stimulation that is actively recruiting participants, run by Pulvinar Neuro. The registered enrollment target is 40 participants, below the 100-participant average among 19 other Depression - Major Depressive Disorder trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06874374, a NA study of Depression - Major Depressive Disorder and Transcranial Alternating Current Stimulation, is actively recruiting participants, sponsored by Pulvinar Neuro.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to study a closed-loop transcranial alternating current stimulation (tACS) device to evaluate feasibility of the product in a clinical trial and collect preliminary data on potential effects on symptoms of depression in people with major depressive disorder.

Interventions

  • DEVICE Sham Comparator
  • DEVICE Closed-loop tACS

Study Locations (1)

North Carolina

  • Carolina Center for Neurostimulation - Chapel Hill

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-04-11
Est. Completion 2026-02-28
Phase NA

Sponsor

Pulvinar Neuro

1 total trials

What the Registry Record Tells You About NCT06874374

The ClinicalTrials.gov registry entry for NCT06874374 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 19 other Depression - Major Depressive Disorder trials with a reported enrollment target (60% lower). The listed sponsor is Pulvinar Neuro, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression - Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Sham Comparator is the first listed.

NCT06874374 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06874374 about?

NCT06874374 is a clinical study titled "Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder". The purpose of this research study is to study a closed-loop transcranial alternating current stimulation (tACS) device to evaluate feasibility of the product in a clinical trial and collect preliminary data on potential effects on symptoms of depression in people with major depressive disorder.

What is the current status of trial NCT06874374?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-04-11. Estimated completion is 2026-02-28.

What conditions does trial NCT06874374 study?

This clinical trial studies the following conditions: Depression - Major Depressive Disorder, Transcranial Alternating Current Stimulation.

What interventions are being tested in trial NCT06874374?

The interventions under investigation include: Sham Comparator (DEVICE), Closed-loop tACS (DEVICE).

Who is sponsoring clinical trial NCT06874374?

This trial is sponsored by Pulvinar Neuro, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06874374 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression - Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.